SCHEMBL21348038

SCHEMBL21348038

Cc1ccc(N(c2ccc(C(C)C)cc2)c2ccc3ccccc3c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.48
NPSR1 Q6W5P4 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CYP2A6 P11509 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
UGT2B7 P16662 1/20 0.44
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
CNR2 P34972 2/20 0.38
ALDH1A1 P00352 2/20 0.37
CYP1A2 P05177 2/20 0.37
TSHR P16473 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
HPGD P15428 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
CNR1 P21554 1/20 0.36
AOC3 Q16853 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13338860 0.93 UGT2B7 (0.50) HTTNPSR1L3MBTL1CYP2A6TDP1
SCHEMBL20048709 0.93 UGT2B7 (0.50) HTTNPSR1L3MBTL1CYP2A6TDP1
SCHEMBL13338861 0.90 UGT2B7 (0.47) L3MBTL1TDP1UGT2B7SLC6A2SLC6A4
SCHEMBL18134989 0.89 CYP2A6 (0.58) HTTNPSR1L3MBTL1CYP2A6TDP1
SCHEMBL12111309 0.89 CYP2A6 (0.58) HTTNPSR1L3MBTL1CYP2A6TDP1
SCHEMBL12744246 0.89 CYP2A6 (0.58) HTTNPSR1L3MBTL1CYP2A6TDP1
SCHEMBL10053532 0.89 CYP2A6 (0.58) HTTNPSR1L3MBTL1CYP2A6TDP1
SCHEMBL16344274 0.88 UGT2B7 (0.46) L3MBTL1CYP2A6UGT2B7CYP1A2TSHR
SCHEMBL13339006 0.88 UGT2B7 (0.46) L3MBTL1CYP2A6UGT2B7CYP1A2TSHR
SCHEMBL15002694 0.87 UGT2B7 (0.44) L3MBTL1TDP1UGT2B7SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190280223-A1 DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS LOMOX LIMITED (GB) 2019-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190280223-A1 DIBENZO[D,B]SILOLE-BASED REACTIVE MESOGENS CCNB1, CCNE2, UBE2G2 HTT 4101/4885NPSR1 2641/4885L3MBTL1 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.